nodes	percent_of_prediction	percent_of_DWPC	metapath
Levorphanol—Palpitations—Loratadine—atopic dermatitis	0.00307	0.00464	CcSEcCtD
Levorphanol—Constipation—Pimecrolimus—atopic dermatitis	0.00305	0.0046	CcSEcCtD
Levorphanol—Feeling abnormal—Diphenhydramine—atopic dermatitis	0.00304	0.00459	CcSEcCtD
Levorphanol—Feeling abnormal—Dimenhydrinate—atopic dermatitis	0.00304	0.00459	CcSEcCtD
Levorphanol—Renal failure—Tacrolimus—atopic dermatitis	0.00299	0.00451	CcSEcCtD
Levorphanol—Urticaria—Dimenhydrinate—atopic dermatitis	0.00293	0.00442	CcSEcCtD
Levorphanol—Urticaria—Diphenhydramine—atopic dermatitis	0.00293	0.00442	CcSEcCtD
Levorphanol—Sweating—Tacrolimus—atopic dermatitis	0.00291	0.0044	CcSEcCtD
Levorphanol—Gastrointestinal pain—Pimecrolimus—atopic dermatitis	0.00291	0.0044	CcSEcCtD
Levorphanol—Dry mouth—Loratadine—atopic dermatitis	0.0029	0.00437	CcSEcCtD
Levorphanol—Pruritus—Fluocinonide—atopic dermatitis	0.00289	0.00437	CcSEcCtD
Levorphanol—Urticaria—Pimecrolimus—atopic dermatitis	0.00283	0.00427	CcSEcCtD
Levorphanol—Abdominal pain—Pimecrolimus—atopic dermatitis	0.00282	0.00425	CcSEcCtD
Levorphanol—Shock—Loratadine—atopic dermatitis	0.00279	0.00422	CcSEcCtD
Levorphanol—Bradycardia—Tacrolimus—atopic dermatitis	0.00278	0.00419	CcSEcCtD
Levorphanol—Tachycardia—Loratadine—atopic dermatitis	0.00277	0.00418	CcSEcCtD
Levorphanol—Dizziness—Fluocinonide—atopic dermatitis	0.0027	0.00408	CcSEcCtD
Levorphanol—Hypotension—Loratadine—atopic dermatitis	0.00265	0.004	CcSEcCtD
Levorphanol—Visual impairment—Tacrolimus—atopic dermatitis	0.00263	0.00397	CcSEcCtD
Levorphanol—Rash—Fluocinonide—atopic dermatitis	0.00258	0.00389	CcSEcCtD
Levorphanol—Dermatitis—Fluocinonide—atopic dermatitis	0.00257	0.00389	CcSEcCtD
Levorphanol—Insomnia—Loratadine—atopic dermatitis	0.00257	0.00388	CcSEcCtD
Levorphanol—Flushing—Tacrolimus—atopic dermatitis	0.00253	0.00382	CcSEcCtD
Levorphanol—Pruritus—Pimecrolimus—atopic dermatitis	0.00252	0.00381	CcSEcCtD
Levorphanol—Lethargy—Hydrocortisone—atopic dermatitis	0.00251	0.00379	CcSEcCtD
Levorphanol—Dyspepsia—Loratadine—atopic dermatitis	0.0025	0.00377	CcSEcCtD
Levorphanol—Dry mouth—Mometasone—atopic dermatitis	0.00248	0.00375	CcSEcCtD
Levorphanol—Affect lability—Prednisolone—atopic dermatitis	0.00248	0.00374	CcSEcCtD
Levorphanol—Amnesia—Methylprednisolone—atopic dermatitis	0.00246	0.00372	CcSEcCtD
Levorphanol—Arrhythmia—Tacrolimus—atopic dermatitis	0.00244	0.00368	CcSEcCtD
Levorphanol—Dizziness—Dimenhydrinate—atopic dermatitis	0.00244	0.00368	CcSEcCtD
Levorphanol—Dizziness—Diphenhydramine—atopic dermatitis	0.00244	0.00368	CcSEcCtD
Levorphanol—Constipation—Loratadine—atopic dermatitis	0.00243	0.00367	CcSEcCtD
Levorphanol—Affect lability—Hydrocortisone—atopic dermatitis	0.00242	0.00366	CcSEcCtD
Levorphanol—Cardiac arrest—Prednisolone—atopic dermatitis	0.0024	0.00362	CcSEcCtD
Levorphanol—Mood swings—Prednisolone—atopic dermatitis	0.00239	0.0036	CcSEcCtD
Levorphanol—Vomiting—Dimenhydrinate—atopic dermatitis	0.00234	0.00354	CcSEcCtD
Levorphanol—Vomiting—Diphenhydramine—atopic dermatitis	0.00234	0.00354	CcSEcCtD
Levorphanol—Cardiac arrest—Hydrocortisone—atopic dermatitis	0.00234	0.00353	CcSEcCtD
Levorphanol—Feeling abnormal—Loratadine—atopic dermatitis	0.00234	0.00353	CcSEcCtD
Levorphanol—Tension—Tacrolimus—atopic dermatitis	0.00233	0.00352	CcSEcCtD
Levorphanol—Mood swings—Hydrocortisone—atopic dermatitis	0.00233	0.00352	CcSEcCtD
Levorphanol—Rash—Diphenhydramine—atopic dermatitis	0.00232	0.00351	CcSEcCtD
Levorphanol—Rash—Dimenhydrinate—atopic dermatitis	0.00232	0.00351	CcSEcCtD
Levorphanol—Dermatitis—Diphenhydramine—atopic dermatitis	0.00232	0.00351	CcSEcCtD
Levorphanol—Dermatitis—Dimenhydrinate—atopic dermatitis	0.00232	0.00351	CcSEcCtD
Levorphanol—Gastrointestinal pain—Loratadine—atopic dermatitis	0.00232	0.0035	CcSEcCtD
Levorphanol—Nervousness—Tacrolimus—atopic dermatitis	0.00231	0.00348	CcSEcCtD
Levorphanol—Muscle spasms—Tacrolimus—atopic dermatitis	0.00228	0.00345	CcSEcCtD
Levorphanol—Affect lability—Triamcinolone—atopic dermatitis	0.00228	0.00344	CcSEcCtD
Levorphanol—Affect lability—Methylprednisolone—atopic dermatitis	0.00227	0.00344	CcSEcCtD
Levorphanol—Vomiting—Pimecrolimus—atopic dermatitis	0.00227	0.00342	CcSEcCtD
Levorphanol—Rash—Pimecrolimus—atopic dermatitis	0.00225	0.00339	CcSEcCtD
Levorphanol—Dermatitis—Pimecrolimus—atopic dermatitis	0.00224	0.00339	CcSEcCtD
Levorphanol—Abdominal pain—Loratadine—atopic dermatitis	0.00224	0.00339	CcSEcCtD
Levorphanol—Cardiac arrest—Triamcinolone—atopic dermatitis	0.0022	0.00333	CcSEcCtD
Levorphanol—Hyperkinesia—Prednisone—atopic dermatitis	0.0022	0.00332	CcSEcCtD
Levorphanol—Cardiac arrest—Methylprednisolone—atopic dermatitis	0.0022	0.00332	CcSEcCtD
Levorphanol—Mood swings—Triamcinolone—atopic dermatitis	0.00219	0.00331	CcSEcCtD
Levorphanol—Mood swings—Methylprednisolone—atopic dermatitis	0.00219	0.00331	CcSEcCtD
Levorphanol—Nausea—Dimenhydrinate—atopic dermatitis	0.00219	0.00331	CcSEcCtD
Levorphanol—Nausea—Diphenhydramine—atopic dermatitis	0.00219	0.00331	CcSEcCtD
Levorphanol—Agitation—Tacrolimus—atopic dermatitis	0.00218	0.0033	CcSEcCtD
Levorphanol—Lethargy—Dexamethasone—atopic dermatitis	0.00214	0.00324	CcSEcCtD
Levorphanol—Lethargy—Betamethasone—atopic dermatitis	0.00214	0.00324	CcSEcCtD
Levorphanol—Dyspepsia—Mometasone—atopic dermatitis	0.00214	0.00324	CcSEcCtD
Levorphanol—Nausea—Pimecrolimus—atopic dermatitis	0.00212	0.0032	CcSEcCtD
Levorphanol—Palpitations—Tacrolimus—atopic dermatitis	0.0021	0.00317	CcSEcCtD
Levorphanol—Affect lability—Betamethasone—atopic dermatitis	0.00207	0.00312	CcSEcCtD
Levorphanol—Affect lability—Dexamethasone—atopic dermatitis	0.00207	0.00312	CcSEcCtD
Levorphanol—Convulsion—Tacrolimus—atopic dermatitis	0.00206	0.00311	CcSEcCtD
Levorphanol—Cardiac arrest—Dexamethasone—atopic dermatitis	0.002	0.00302	CcSEcCtD
Levorphanol—Cardiac arrest—Betamethasone—atopic dermatitis	0.002	0.00302	CcSEcCtD
Levorphanol—Gastrointestinal pain—Mometasone—atopic dermatitis	0.00199	0.00301	CcSEcCtD
Levorphanol—Mood swings—Dexamethasone—atopic dermatitis	0.00199	0.00301	CcSEcCtD
Levorphanol—Mood swings—Betamethasone—atopic dermatitis	0.00199	0.00301	CcSEcCtD
Levorphanol—Dry mouth—Tacrolimus—atopic dermatitis	0.00198	0.00299	CcSEcCtD
Levorphanol—Confusional state—Tacrolimus—atopic dermatitis	0.00195	0.00295	CcSEcCtD
Levorphanol—Amnesia—Prednisone—atopic dermatitis	0.00195	0.00294	CcSEcCtD
Levorphanol—Abdominal pain—Mometasone—atopic dermatitis	0.00193	0.00291	CcSEcCtD
Levorphanol—Shock—Tacrolimus—atopic dermatitis	0.00191	0.00288	CcSEcCtD
Levorphanol—Tachycardia—Tacrolimus—atopic dermatitis	0.00189	0.00286	CcSEcCtD
Levorphanol—Dizziness—Loratadine—atopic dermatitis	0.00188	0.00283	CcSEcCtD
Levorphanol—Hyperhidrosis—Tacrolimus—atopic dermatitis	0.00187	0.00283	CcSEcCtD
Levorphanol—Lethargy—Prednisone—atopic dermatitis	0.00187	0.00282	CcSEcCtD
Levorphanol—Hypotension—Tacrolimus—atopic dermatitis	0.00181	0.00274	CcSEcCtD
Levorphanol—Pruritus—Fluocinolone Acetonide—atopic dermatitis	0.0018	0.00273	CcSEcCtD
Levorphanol—Vomiting—Loratadine—atopic dermatitis	0.0018	0.00273	CcSEcCtD
Levorphanol—Affect lability—Prednisone—atopic dermatitis	0.0018	0.00272	CcSEcCtD
Levorphanol—Rash—Loratadine—atopic dermatitis	0.00179	0.0027	CcSEcCtD
Levorphanol—Dermatitis—Loratadine—atopic dermatitis	0.00179	0.0027	CcSEcCtD
Levorphanol—Bradycardia—Prednisolone—atopic dermatitis	0.00177	0.00268	CcSEcCtD
Levorphanol—Insomnia—Tacrolimus—atopic dermatitis	0.00175	0.00265	CcSEcCtD
Levorphanol—Cardiac arrest—Prednisone—atopic dermatitis	0.00174	0.00263	CcSEcCtD
Levorphanol—OPRK1—GPCR ligand binding—CCL27—atopic dermatitis	0.00174	0.00515	CbGpPWpGaD
Levorphanol—Mood swings—Prednisone—atopic dermatitis	0.00173	0.00262	CcSEcCtD
Levorphanol—Bradycardia—Hydrocortisone—atopic dermatitis	0.00173	0.00262	CcSEcCtD
Levorphanol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.00173	0.00512	CbGpPWpGaD
Levorphanol—Pruritus—Mometasone—atopic dermatitis	0.00172	0.0026	CcSEcCtD
Levorphanol—Sweating—Methylprednisolone—atopic dermatitis	0.00171	0.00258	CcSEcCtD
Levorphanol—Dyspepsia—Tacrolimus—atopic dermatitis	0.00171	0.00258	CcSEcCtD
Levorphanol—OPRM1—Peptide ligand-binding receptors—CCR3—atopic dermatitis	0.0017	0.00502	CbGpPWpGaD
Levorphanol—OPRK1—G alpha (i) signalling events—CCR3—atopic dermatitis	0.00169	0.00501	CbGpPWpGaD
Levorphanol—OPRM1—TCR Signaling Pathway—CCR5—atopic dermatitis	0.00169	0.005	CbGpPWpGaD
Levorphanol—OPRD1—G alpha (i) signalling events—CXCR3—atopic dermatitis	0.00169	0.00499	CbGpPWpGaD
Levorphanol—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.00169	0.00255	CcSEcCtD
Levorphanol—Nausea—Loratadine—atopic dermatitis	0.00169	0.00255	CcSEcCtD
Levorphanol—Visual impairment—Prednisolone—atopic dermatitis	0.00168	0.00254	CcSEcCtD
Levorphanol—Constipation—Tacrolimus—atopic dermatitis	0.00166	0.0025	CcSEcCtD
Levorphanol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.00165	0.00489	CbGpPWpGaD
Levorphanol—OPRM1—GPCR ligand binding—CCL22—atopic dermatitis	0.00165	0.00488	CbGpPWpGaD
Levorphanol—Bradycardia—Triamcinolone—atopic dermatitis	0.00163	0.00246	CcSEcCtD
Levorphanol—Bradycardia—Methylprednisolone—atopic dermatitis	0.00163	0.00246	CcSEcCtD
Levorphanol—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.00162	0.00245	CcSEcCtD
Levorphanol—OPRD1—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.00162	0.00479	CbGpPWpGaD
Levorphanol—Rash—Fluocinolone Acetonide—atopic dermatitis	0.00161	0.00243	CcSEcCtD
Levorphanol—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.00161	0.00243	CcSEcCtD
Levorphanol—Feeling abnormal—Tacrolimus—atopic dermatitis	0.0016	0.00241	CcSEcCtD
Levorphanol—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.00158	0.00239	CcSEcCtD
Levorphanol—OPRK1—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.00157	0.00465	CbGpPWpGaD
Levorphanol—OPRD1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.00157	0.00464	CbGpPWpGaD
Levorphanol—OPRK1—GPCR ligand binding—CCL17—atopic dermatitis	0.00156	0.00462	CbGpPWpGaD
Levorphanol—Arrhythmia—Prednisolone—atopic dermatitis	0.00156	0.00235	CcSEcCtD
Levorphanol—Vomiting—Mometasone—atopic dermatitis	0.00155	0.00234	CcSEcCtD
Levorphanol—Visual impairment—Methylprednisolone—atopic dermatitis	0.00154	0.00233	CcSEcCtD
Levorphanol—Urticaria—Tacrolimus—atopic dermatitis	0.00154	0.00233	CcSEcCtD
Levorphanol—Rash—Mometasone—atopic dermatitis	0.00154	0.00232	CcSEcCtD
Levorphanol—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00154	0.00454	CbGpPWpGaD
Levorphanol—Dermatitis—Mometasone—atopic dermatitis	0.00153	0.00232	CcSEcCtD
Levorphanol—Abdominal pain—Tacrolimus—atopic dermatitis	0.00153	0.00231	CcSEcCtD
Levorphanol—Arrhythmia—Hydrocortisone—atopic dermatitis	0.00152	0.0023	CcSEcCtD
Levorphanol—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.00151	0.00229	CcSEcCtD
Levorphanol—OPRM1—Peptide ligand-binding receptors—NPS—atopic dermatitis	0.00151	0.00447	CbGpPWpGaD
Levorphanol—OPRM1—Peptide ligand-binding receptors—TAC1—atopic dermatitis	0.00151	0.00447	CbGpPWpGaD
Levorphanol—OPRM1—Peptide ligand-binding receptors—CXCR3—atopic dermatitis	0.00148	0.00439	CbGpPWpGaD
Levorphanol—Bradycardia—Betamethasone—atopic dermatitis	0.00148	0.00224	CcSEcCtD
Levorphanol—Bradycardia—Dexamethasone—atopic dermatitis	0.00148	0.00224	CcSEcCtD
Levorphanol—OPRK1—G alpha (i) signalling events—CXCR3—atopic dermatitis	0.00148	0.00438	CbGpPWpGaD
Levorphanol—OPRM1—GPCR ligand binding—CCL27—atopic dermatitis	0.00147	0.00435	CbGpPWpGaD
Levorphanol—Nausea—Mometasone—atopic dermatitis	0.00145	0.00218	CcSEcCtD
Levorphanol—OPRD1—GPCR ligand binding—CCL11—atopic dermatitis	0.00143	0.00424	CbGpPWpGaD
Levorphanol—OPRM1—TCR Signaling Pathway—NFKBIA—atopic dermatitis	0.00143	0.00424	CbGpPWpGaD
Levorphanol—Arrhythmia—Triamcinolone—atopic dermatitis	0.00143	0.00216	CcSEcCtD
Levorphanol—OPRM1—G alpha (i) signalling events—CCR3—atopic dermatitis	0.00143	0.00423	CbGpPWpGaD
Levorphanol—Arrhythmia—Methylprednisolone—atopic dermatitis	0.00143	0.00216	CcSEcCtD
Levorphanol—OPRK1—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.00142	0.0042	CbGpPWpGaD
Levorphanol—Visual impairment—Dexamethasone—atopic dermatitis	0.0014	0.00212	CcSEcCtD
Levorphanol—Visual impairment—Betamethasone—atopic dermatitis	0.0014	0.00212	CcSEcCtD
Levorphanol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.0014	0.00413	CbGpPWpGaD
Levorphanol—OPRD1—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.00139	0.00412	CbGpPWpGaD
Levorphanol—OPRK1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.00137	0.00406	CbGpPWpGaD
Levorphanol—Pruritus—Tacrolimus—atopic dermatitis	0.00137	0.00207	CcSEcCtD
Levorphanol—OPRD1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00137	0.00405	CbGpPWpGaD
Levorphanol—OPRD1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.00137	0.00405	CbGpPWpGaD
Levorphanol—OPRD1—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.00136	0.00404	CbGpPWpGaD
Levorphanol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00135	0.00398	CbGpPWpGaD
Levorphanol—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.00134	0.00397	CbGpPWpGaD
Levorphanol—OPRM1—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.00133	0.00393	CbGpPWpGaD
Levorphanol—OPRM1—GPCR ligand binding—CCL17—atopic dermatitis	0.00132	0.0039	CbGpPWpGaD
Levorphanol—Convulsion—Prednisolone—atopic dermatitis	0.00131	0.00199	CcSEcCtD
Levorphanol—Arrhythmia—Dexamethasone—atopic dermatitis	0.0013	0.00196	CcSEcCtD
Levorphanol—Arrhythmia—Betamethasone—atopic dermatitis	0.0013	0.00196	CcSEcCtD
Levorphanol—Bradycardia—Prednisone—atopic dermatitis	0.00129	0.00195	CcSEcCtD
Levorphanol—Convulsion—Hydrocortisone—atopic dermatitis	0.00128	0.00194	CcSEcCtD
Levorphanol—Dizziness—Tacrolimus—atopic dermatitis	0.00128	0.00194	CcSEcCtD
Levorphanol—OPRK1—GPCR ligand binding—CCL11—atopic dermatitis	0.00126	0.00372	CbGpPWpGaD
Levorphanol—OPRD1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.00125	0.00371	CbGpPWpGaD
Levorphanol—OPRM1—G alpha (i) signalling events—CXCR3—atopic dermatitis	0.00125	0.0037	CbGpPWpGaD
Levorphanol—Vomiting—Tacrolimus—atopic dermatitis	0.00123	0.00186	CcSEcCtD
Levorphanol—Rash—Tacrolimus—atopic dermatitis	0.00122	0.00185	CcSEcCtD
Levorphanol—Dermatitis—Tacrolimus—atopic dermatitis	0.00122	0.00184	CcSEcCtD
Levorphanol—OPRK1—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.00122	0.00361	CbGpPWpGaD
Levorphanol—Shock—Prednisolone—atopic dermatitis	0.00122	0.00184	CcSEcCtD
Levorphanol—Convulsion—Triamcinolone—atopic dermatitis	0.00121	0.00183	CcSEcCtD
Levorphanol—Tachycardia—Prednisolone—atopic dermatitis	0.00121	0.00182	CcSEcCtD
Levorphanol—Convulsion—Methylprednisolone—atopic dermatitis	0.00121	0.00182	CcSEcCtD
Levorphanol—OPRK1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.0012	0.00355	CbGpPWpGaD
Levorphanol—OPRK1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.0012	0.00355	CbGpPWpGaD
Levorphanol—OPRM1—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.0012	0.00355	CbGpPWpGaD
Levorphanol—Hyperhidrosis—Prednisolone—atopic dermatitis	0.0012	0.00181	CcSEcCtD
Levorphanol—OPRK1—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.0012	0.00354	CbGpPWpGaD
Levorphanol—Shock—Hydrocortisone—atopic dermatitis	0.00119	0.0018	CcSEcCtD
Levorphanol—Tachycardia—Hydrocortisone—atopic dermatitis	0.00118	0.00178	CcSEcCtD
Levorphanol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.00118	0.00348	CbGpPWpGaD
Levorphanol—Flushing—Prednisone—atopic dermatitis	0.00118	0.00177	CcSEcCtD
Levorphanol—OPRD1—G alpha (i) signalling events—CCL5—atopic dermatitis	0.00117	0.00348	CbGpPWpGaD
Levorphanol—OPRD1—GPCR ligand binding—CCR3—atopic dermatitis	0.00117	0.00346	CbGpPWpGaD
Levorphanol—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.00117	0.00177	CcSEcCtD
Levorphanol—Dry mouth—Triamcinolone—atopic dermatitis	0.00116	0.00175	CcSEcCtD
Levorphanol—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.00116	0.00344	CbGpPWpGaD
Levorphanol—Nausea—Tacrolimus—atopic dermatitis	0.00115	0.00174	CcSEcCtD
Levorphanol—Confusional state—Methylprednisolone—atopic dermatitis	0.00115	0.00173	CcSEcCtD
Levorphanol—OPRD1—Signaling by GPCR—CCL22—atopic dermatitis	0.00114	0.00338	CbGpPWpGaD
Levorphanol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00114	0.00337	CbGpPWpGaD
Levorphanol—Arrhythmia—Prednisone—atopic dermatitis	0.00113	0.00171	CcSEcCtD
Levorphanol—Hypotension—Hydrocortisone—atopic dermatitis	0.00113	0.00171	CcSEcCtD
Levorphanol—OPRD1—GPCR downstream signaling—CCL27—atopic dermatitis	0.00112	0.00332	CbGpPWpGaD
Levorphanol—Shock—Triamcinolone—atopic dermatitis	0.00112	0.00169	CcSEcCtD
Levorphanol—Insomnia—Prednisolone—atopic dermatitis	0.00112	0.00169	CcSEcCtD
Levorphanol—Shock—Methylprednisolone—atopic dermatitis	0.00112	0.00169	CcSEcCtD
Levorphanol—Tachycardia—Triamcinolone—atopic dermatitis	0.00111	0.00168	CcSEcCtD
Levorphanol—Tachycardia—Methylprednisolone—atopic dermatitis	0.00111	0.00167	CcSEcCtD
Levorphanol—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.0011	0.00166	CcSEcCtD
Levorphanol—OPRK1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.0011	0.00325	CbGpPWpGaD
Levorphanol—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.0011	0.00166	CcSEcCtD
Levorphanol—Convulsion—Dexamethasone—atopic dermatitis	0.0011	0.00166	CcSEcCtD
Levorphanol—Convulsion—Betamethasone—atopic dermatitis	0.0011	0.00166	CcSEcCtD
Levorphanol—Insomnia—Hydrocortisone—atopic dermatitis	0.00109	0.00165	CcSEcCtD
Levorphanol—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.00108	0.00321	CbGpPWpGaD
Levorphanol—Dyspepsia—Hydrocortisone—atopic dermatitis	0.00106	0.00161	CcSEcCtD
Levorphanol—OPRM1—GPCR ligand binding—CCL11—atopic dermatitis	0.00106	0.00315	CbGpPWpGaD
Levorphanol—Hypotension—Methylprednisolone—atopic dermatitis	0.00106	0.0016	CcSEcCtD
Levorphanol—OPRM1—TCR Signaling Pathway—CD4—atopic dermatitis	0.00106	0.00314	CbGpPWpGaD
Levorphanol—OPRD1—G alpha (i) signalling events—CCR5—atopic dermatitis	0.00106	0.00313	CbGpPWpGaD
Levorphanol—OPRD1—GPCR ligand binding—TAC1—atopic dermatitis	0.00104	0.00308	CbGpPWpGaD
Levorphanol—OPRD1—GPCR ligand binding—NPS—atopic dermatitis	0.00104	0.00308	CbGpPWpGaD
Levorphanol—OPRM1—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.00103	0.00305	CbGpPWpGaD
Levorphanol—OPRK1—G alpha (i) signalling events—CCL5—atopic dermatitis	0.00103	0.00305	CbGpPWpGaD
Levorphanol—Insomnia—Triamcinolone—atopic dermatitis	0.00103	0.00156	CcSEcCtD
Levorphanol—Insomnia—Methylprednisolone—atopic dermatitis	0.00103	0.00155	CcSEcCtD
Levorphanol—OPRK1—GPCR ligand binding—CCR3—atopic dermatitis	0.00103	0.00303	CbGpPWpGaD
Levorphanol—OPRD1—GPCR ligand binding—CXCR3—atopic dermatitis	0.00102	0.00302	CbGpPWpGaD
Levorphanol—Feeling abnormal—Prednisolone—atopic dermatitis	0.00102	0.00154	CcSEcCtD
Levorphanol—OPRD1—Signaling by GPCR—CCL27—atopic dermatitis	0.00102	0.00301	CbGpPWpGaD
Levorphanol—Shock—Dexamethasone—atopic dermatitis	0.00102	0.00154	CcSEcCtD
Levorphanol—Shock—Betamethasone—atopic dermatitis	0.00102	0.00154	CcSEcCtD
Levorphanol—OPRM1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00101	0.003	CbGpPWpGaD
Levorphanol—OPRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.00101	0.003	CbGpPWpGaD
Levorphanol—Agitation—Prednisone—atopic dermatitis	0.00101	0.00153	CcSEcCtD
Levorphanol—OPRM1—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.00101	0.00299	CbGpPWpGaD
Levorphanol—Tachycardia—Betamethasone—atopic dermatitis	0.00101	0.00152	CcSEcCtD
Levorphanol—Tachycardia—Dexamethasone—atopic dermatitis	0.00101	0.00152	CcSEcCtD
Levorphanol—Dyspepsia—Triamcinolone—atopic dermatitis	0.001	0.00151	CcSEcCtD
Levorphanol—OPRK1—Signaling by GPCR—CCL22—atopic dermatitis	0.001	0.00296	CbGpPWpGaD
Levorphanol—Dyspepsia—Methylprednisolone—atopic dermatitis	0.001	0.00151	CcSEcCtD
Levorphanol—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000999	0.00151	CcSEcCtD
Levorphanol—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000999	0.00151	CcSEcCtD
Levorphanol—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000996	0.0015	CcSEcCtD
Levorphanol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000994	0.00294	CbGpPWpGaD
Levorphanol—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000989	0.00149	CcSEcCtD
Levorphanol—Urticaria—Prednisolone—atopic dermatitis	0.000984	0.00149	CcSEcCtD
Levorphanol—OPRK1—GPCR downstream signaling—CCL27—atopic dermatitis	0.000983	0.00291	CbGpPWpGaD
Levorphanol—OPRD1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000982	0.00291	CbGpPWpGaD
Levorphanol—OPRM1—TCR Signaling Pathway—IL1B—atopic dermatitis	0.00098	0.0029	CbGpPWpGaD
Levorphanol—Hypotension—Dexamethasone—atopic dermatitis	0.000965	0.00146	CcSEcCtD
Levorphanol—Hypotension—Betamethasone—atopic dermatitis	0.000965	0.00146	CcSEcCtD
Levorphanol—Urticaria—Hydrocortisone—atopic dermatitis	0.000961	0.00145	CcSEcCtD
Levorphanol—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000956	0.00144	CcSEcCtD
Levorphanol—Convulsion—Prednisone—atopic dermatitis	0.000955	0.00144	CcSEcCtD
Levorphanol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000951	0.00281	CbGpPWpGaD
Levorphanol—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000938	0.00142	CcSEcCtD
Levorphanol—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000936	0.00141	CcSEcCtD
Levorphanol—Insomnia—Dexamethasone—atopic dermatitis	0.000934	0.00141	CcSEcCtD
Levorphanol—Insomnia—Betamethasone—atopic dermatitis	0.000934	0.00141	CcSEcCtD
Levorphanol—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000934	0.00276	CbGpPWpGaD
Levorphanol—OPRM1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.000929	0.00275	CbGpPWpGaD
Levorphanol—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000929	0.0014	CcSEcCtD
Levorphanol—OPRK1—G alpha (i) signalling events—CCR5—atopic dermatitis	0.000928	0.00275	CbGpPWpGaD
Levorphanol—OPRK1—GPCR ligand binding—NPS—atopic dermatitis	0.000914	0.0027	CbGpPWpGaD
Levorphanol—OPRK1—GPCR ligand binding—TAC1—atopic dermatitis	0.000914	0.0027	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—CCL17—atopic dermatitis	0.000913	0.0027	CbGpPWpGaD
Levorphanol—Dyspepsia—Betamethasone—atopic dermatitis	0.000909	0.00137	CcSEcCtD
Levorphanol—Dyspepsia—Dexamethasone—atopic dermatitis	0.000909	0.00137	CcSEcCtD
Levorphanol—Urticaria—Triamcinolone—atopic dermatitis	0.000904	0.00137	CcSEcCtD
Levorphanol—Urticaria—Methylprednisolone—atopic dermatitis	0.000902	0.00136	CcSEcCtD
Levorphanol—OPRM1—TCR Signaling Pathway—MAPK8—atopic dermatitis	0.000899	0.00266	CbGpPWpGaD
Levorphanol—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000898	0.00136	CcSEcCtD
Levorphanol—OPRK1—GPCR ligand binding—CXCR3—atopic dermatitis	0.000896	0.00265	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—CCL27—atopic dermatitis	0.000893	0.00264	CbGpPWpGaD
Levorphanol—Shock—Prednisone—atopic dermatitis	0.000885	0.00134	CcSEcCtD
Levorphanol—Tachycardia—Prednisone—atopic dermatitis	0.000878	0.00133	CcSEcCtD
Levorphanol—OPRM1—G alpha (i) signalling events—CCL5—atopic dermatitis	0.00087	0.00258	CbGpPWpGaD
Levorphanol—Hyperhidrosis—Prednisone—atopic dermatitis	0.00087	0.00131	CcSEcCtD
Levorphanol—OPRM1—GPCR ligand binding—CCR3—atopic dermatitis	0.000866	0.00256	CbGpPWpGaD
Levorphanol—OPRK1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000861	0.00255	CbGpPWpGaD
Levorphanol—Pruritus—Hydrocortisone—atopic dermatitis	0.000855	0.00129	CcSEcCtD
Levorphanol—Feeling abnormal—Betamethasone—atopic dermatitis	0.000851	0.00129	CcSEcCtD
Levorphanol—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000851	0.00129	CcSEcCtD
Levorphanol—OPRM1—Signaling by GPCR—CCL22—atopic dermatitis	0.000846	0.0025	CbGpPWpGaD
Levorphanol—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000845	0.00128	CcSEcCtD
Levorphanol—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000845	0.00128	CcSEcCtD
Levorphanol—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000841	0.00249	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—CCL27—atopic dermatitis	0.000831	0.00246	CbGpPWpGaD
Levorphanol—OPRD1—GPCR ligand binding—CXCL10—atopic dermatitis	0.000826	0.00244	CbGpPWpGaD
Levorphanol—Urticaria—Dexamethasone—atopic dermatitis	0.000821	0.00124	CcSEcCtD
Levorphanol—Urticaria—Betamethasone—atopic dermatitis	0.000821	0.00124	CcSEcCtD
Levorphanol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000819	0.00242	CbGpPWpGaD
Levorphanol—Dizziness—Prednisolone—atopic dermatitis	0.000819	0.00124	CcSEcCtD
Levorphanol—Abdominal pain—Dexamethasone—atopic dermatitis	0.000817	0.00123	CcSEcCtD
Levorphanol—Abdominal pain—Betamethasone—atopic dermatitis	0.000817	0.00123	CcSEcCtD
Levorphanol—Insomnia—Prednisone—atopic dermatitis	0.000814	0.00123	CcSEcCtD
Levorphanol—Pruritus—Triamcinolone—atopic dermatitis	0.000805	0.00122	CcSEcCtD
Levorphanol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000804	0.00238	CbGpPWpGaD
Levorphanol—Pruritus—Methylprednisolone—atopic dermatitis	0.000804	0.00121	CcSEcCtD
Levorphanol—OPRK1—Signaling by GPCR—CCL17—atopic dermatitis	0.000801	0.00237	CbGpPWpGaD
Levorphanol—Dizziness—Hydrocortisone—atopic dermatitis	0.0008	0.00121	CcSEcCtD
Levorphanol—Dyspepsia—Prednisone—atopic dermatitis	0.000792	0.0012	CcSEcCtD
Levorphanol—OPRM1—G alpha (i) signalling events—CCR5—atopic dermatitis	0.000784	0.00232	CbGpPWpGaD
Levorphanol—Rash—Prednisolone—atopic dermatitis	0.000781	0.00118	CcSEcCtD
Levorphanol—Dermatitis—Prednisolone—atopic dermatitis	0.00078	0.00118	CcSEcCtD
Levorphanol—OPRM1—GPCR ligand binding—TAC1—atopic dermatitis	0.000772	0.00229	CbGpPWpGaD
Levorphanol—OPRM1—GPCR ligand binding—NPS—atopic dermatitis	0.000772	0.00229	CbGpPWpGaD
Levorphanol—Constipation—Prednisone—atopic dermatitis	0.000769	0.00116	CcSEcCtD
Levorphanol—Vomiting—Hydrocortisone—atopic dermatitis	0.000769	0.00116	CcSEcCtD
Levorphanol—Rash—Hydrocortisone—atopic dermatitis	0.000762	0.00115	CcSEcCtD
Levorphanol—Dermatitis—Hydrocortisone—atopic dermatitis	0.000762	0.00115	CcSEcCtD
Levorphanol—OPRD1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000758	0.00224	CbGpPWpGaD
Levorphanol—OPRM1—GPCR ligand binding—CXCR3—atopic dermatitis	0.000757	0.00224	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—CCL27—atopic dermatitis	0.000754	0.00223	CbGpPWpGaD
Levorphanol—Dizziness—Triamcinolone—atopic dermatitis	0.000753	0.00114	CcSEcCtD
Levorphanol—Dizziness—Methylprednisolone—atopic dermatitis	0.000751	0.00113	CcSEcCtD
Levorphanol—Feeling abnormal—Prednisone—atopic dermatitis	0.000741	0.00112	CcSEcCtD
Levorphanol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000738	0.00218	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—CCL11—atopic dermatitis	0.000736	0.00218	CbGpPWpGaD
Levorphanol—Gastrointestinal pain—Prednisone—atopic dermatitis	0.000736	0.00111	CcSEcCtD
Levorphanol—Nausea—Prednisolone—atopic dermatitis	0.000735	0.00111	CcSEcCtD
Levorphanol—Pruritus—Dexamethasone—atopic dermatitis	0.000731	0.0011	CcSEcCtD
Levorphanol—Pruritus—Betamethasone—atopic dermatitis	0.000731	0.0011	CcSEcCtD
Levorphanol—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000728	0.00215	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—FCER2—atopic dermatitis	0.000726	0.00215	CbGpPWpGaD
Levorphanol—OPRK1—GPCR ligand binding—CXCL10—atopic dermatitis	0.000724	0.00214	CbGpPWpGaD
Levorphanol—Vomiting—Triamcinolone—atopic dermatitis	0.000724	0.00109	CcSEcCtD
Levorphanol—Vomiting—Methylprednisolone—atopic dermatitis	0.000722	0.00109	CcSEcCtD
Levorphanol—Nausea—Hydrocortisone—atopic dermatitis	0.000718	0.00108	CcSEcCtD
Levorphanol—Rash—Triamcinolone—atopic dermatitis	0.000718	0.00108	CcSEcCtD
Levorphanol—Dermatitis—Triamcinolone—atopic dermatitis	0.000717	0.00108	CcSEcCtD
Levorphanol—Rash—Methylprednisolone—atopic dermatitis	0.000716	0.00108	CcSEcCtD
Levorphanol—Dermatitis—Methylprednisolone—atopic dermatitis	0.000716	0.00108	CcSEcCtD
Levorphanol—Urticaria—Prednisone—atopic dermatitis	0.000715	0.00108	CcSEcCtD
Levorphanol—Abdominal pain—Prednisone—atopic dermatitis	0.000711	0.00107	CcSEcCtD
Levorphanol—OPRD1—GPCR ligand binding—CCL5—atopic dermatitis	0.000711	0.0021	CbGpPWpGaD
Levorphanol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000692	0.00205	CbGpPWpGaD
Levorphanol—Dizziness—Dexamethasone—atopic dermatitis	0.000683	0.00103	CcSEcCtD
Levorphanol—Dizziness—Betamethasone—atopic dermatitis	0.000683	0.00103	CcSEcCtD
Levorphanol—OPRM1—Signaling by GPCR—CCL17—atopic dermatitis	0.000677	0.002	CbGpPWpGaD
Levorphanol—Nausea—Triamcinolone—atopic dermatitis	0.000676	0.00102	CcSEcCtD
Levorphanol—Nausea—Methylprednisolone—atopic dermatitis	0.000675	0.00102	CcSEcCtD
Levorphanol—OPRD1—Signaling Pathways—CCL22—atopic dermatitis	0.000675	0.002	CbGpPWpGaD
Levorphanol—OPRK1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000665	0.00197	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—CCR3—atopic dermatitis	0.000661	0.00196	CbGpPWpGaD
Levorphanol—Vomiting—Betamethasone—atopic dermatitis	0.000657	0.000992	CcSEcCtD
Levorphanol—Vomiting—Dexamethasone—atopic dermatitis	0.000657	0.000992	CcSEcCtD
Levorphanol—Rash—Dexamethasone—atopic dermatitis	0.000651	0.000984	CcSEcCtD
Levorphanol—Rash—Betamethasone—atopic dermatitis	0.000651	0.000984	CcSEcCtD
Levorphanol—Dermatitis—Dexamethasone—atopic dermatitis	0.000651	0.000983	CcSEcCtD
Levorphanol—Dermatitis—Betamethasone—atopic dermatitis	0.000651	0.000983	CcSEcCtD
Levorphanol—OPRK1—Signaling by GPCR—CCL11—atopic dermatitis	0.000645	0.00191	CbGpPWpGaD
Levorphanol—OPRD1—GPCR ligand binding—CCR5—atopic dermatitis	0.000641	0.0019	CbGpPWpGaD
Levorphanol—OPRD1—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.00064	0.00189	CbGpPWpGaD
Levorphanol—Pruritus—Prednisone—atopic dermatitis	0.000636	0.000961	CcSEcCtD
Levorphanol—OPRK1—Signaling Pathways—FCER2—atopic dermatitis	0.000636	0.00188	CbGpPWpGaD
Levorphanol—OPRK1—GPCR ligand binding—CCL5—atopic dermatitis	0.000623	0.00185	CbGpPWpGaD
Levorphanol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000623	0.00184	CbGpPWpGaD
Levorphanol—Nausea—Dexamethasone—atopic dermatitis	0.000614	0.000927	CcSEcCtD
Levorphanol—Nausea—Betamethasone—atopic dermatitis	0.000614	0.000927	CcSEcCtD
Levorphanol—OPRM1—GPCR ligand binding—CXCL10—atopic dermatitis	0.000612	0.00181	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CCL27—atopic dermatitis	0.000601	0.00178	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—CCR3—atopic dermatitis	0.0006	0.00178	CbGpPWpGaD
Levorphanol—Dizziness—Prednisone—atopic dermatitis	0.000595	0.000899	CcSEcCtD
Levorphanol—OPRK1—Signaling Pathways—CCL22—atopic dermatitis	0.000592	0.00175	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—NPS—atopic dermatitis	0.000589	0.00174	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—TAC1—atopic dermatitis	0.000589	0.00174	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—CCR3—atopic dermatitis	0.000579	0.00171	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000577	0.00171	CbGpPWpGaD
Levorphanol—OPRM1—TCR Signaling Pathway—IL6—atopic dermatitis	0.000574	0.0017	CbGpPWpGaD
Levorphanol—Vomiting—Prednisone—atopic dermatitis	0.000572	0.000864	CcSEcCtD
Levorphanol—Rash—Prednisone—atopic dermatitis	0.000567	0.000857	CcSEcCtD
Levorphanol—Dermatitis—Prednisone—atopic dermatitis	0.000567	0.000856	CcSEcCtD
Levorphanol—OPRM1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000562	0.00166	CbGpPWpGaD
Levorphanol—OPRK1—GPCR ligand binding—CCR5—atopic dermatitis	0.000562	0.00166	CbGpPWpGaD
Levorphanol—OPRK1—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.000561	0.00166	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—IL5—atopic dermatitis	0.000547	0.00162	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—CCL11—atopic dermatitis	0.000545	0.00161	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CCL17—atopic dermatitis	0.000539	0.0016	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—FCER2—atopic dermatitis	0.000538	0.00159	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—NPS—atopic dermatitis	0.000535	0.00158	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—TAC1—atopic dermatitis	0.000535	0.00158	CbGpPWpGaD
Levorphanol—Nausea—Prednisone—atopic dermatitis	0.000534	0.000807	CcSEcCtD
Levorphanol—OPRK1—Signaling Pathways—CCL27—atopic dermatitis	0.000527	0.00156	CbGpPWpGaD
Levorphanol—OPRM1—GPCR ligand binding—CCL5—atopic dermatitis	0.000527	0.00156	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—CCR3—atopic dermatitis	0.000526	0.00156	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—CXCR3—atopic dermatitis	0.000524	0.00155	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—NPS—atopic dermatitis	0.000516	0.00153	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—TAC1—atopic dermatitis	0.000516	0.00153	CbGpPWpGaD
Levorphanol—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000509	0.00151	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000506	0.0015	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CCL22—atopic dermatitis	0.0005	0.00148	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—IL5—atopic dermatitis	0.000497	0.00147	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—CCR3—atopic dermatitis	0.00049	0.00145	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—KIF3A—atopic dermatitis	0.000481	0.00142	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—IL5—atopic dermatitis	0.00048	0.00142	CbGpPWpGaD
Levorphanol—OPRM1—GPCR ligand binding—CCR5—atopic dermatitis	0.000475	0.0014	CbGpPWpGaD
Levorphanol—OPRM1—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.000474	0.0014	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CCL17—atopic dermatitis	0.000473	0.0014	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—NPS—atopic dermatitis	0.000469	0.00139	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—TAC1—atopic dermatitis	0.000469	0.00139	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000467	0.00138	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—CXCR3—atopic dermatitis	0.00046	0.00136	CbGpPWpGaD
Levorphanol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000446	0.00132	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CCL27—atopic dermatitis	0.000446	0.00132	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—CCR3—atopic dermatitis	0.000445	0.00132	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—NPS—atopic dermatitis	0.000436	0.00129	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—TAC1—atopic dermatitis	0.000436	0.00129	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—IL5—atopic dermatitis	0.000436	0.00129	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CMA1—atopic dermatitis	0.000435	0.00129	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CCL11—atopic dermatitis	0.000435	0.00129	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000428	0.00127	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—CXCL10—atopic dermatitis	0.000424	0.00125	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—KIF3A—atopic dermatitis	0.000422	0.00125	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000409	0.00121	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—STAT6—atopic dermatitis	0.000409	0.00121	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—IL5—atopic dermatitis	0.000406	0.0012	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—CCL5—atopic dermatitis	0.000402	0.00119	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CCL17—atopic dermatitis	0.0004	0.00118	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—NPS—atopic dermatitis	0.000396	0.00117	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—TAC1—atopic dermatitis	0.000396	0.00117	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—CXCR3—atopic dermatitis	0.000389	0.00115	CbGpPWpGaD
Levorphanol—OPRD1—GPCR ligand binding—CXCL8—atopic dermatitis	0.000387	0.00115	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CCL11—atopic dermatitis	0.000381	0.00113	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CMA1—atopic dermatitis	0.000381	0.00113	CbGpPWpGaD
Levorphanol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000377	0.00112	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—CXCL10—atopic dermatitis	0.000372	0.0011	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—IL5—atopic dermatitis	0.000368	0.00109	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—CCL5—atopic dermatitis	0.000365	0.00108	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—CCR5—atopic dermatitis	0.000362	0.00107	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—STAT6—atopic dermatitis	0.000358	0.00106	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—KIF3A—atopic dermatitis	0.000356	0.00105	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CCR3—atopic dermatitis	0.000354	0.00105	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—CCL5—atopic dermatitis	0.000352	0.00104	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000346	0.00102	CbGpPWpGaD
Levorphanol—OPRK1—GPCR ligand binding—CXCL8—atopic dermatitis	0.00034	0.001	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—CCR5—atopic dermatitis	0.000329	0.000973	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CCL11—atopic dermatitis	0.000322	0.000954	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CMA1—atopic dermatitis	0.000322	0.000954	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—CCL5—atopic dermatitis	0.00032	0.000947	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—CCR5—atopic dermatitis	0.000317	0.000939	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—NPS—atopic dermatitis	0.000316	0.000935	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—TAC1—atopic dermatitis	0.000316	0.000935	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—CXCL10—atopic dermatitis	0.000314	0.00093	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CCR3—atopic dermatitis	0.000311	0.00092	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CXCR3—atopic dermatitis	0.00031	0.000917	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—STAT6—atopic dermatitis	0.000303	0.000896	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—CCL5—atopic dermatitis	0.000298	0.000881	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—IL5—atopic dermatitis	0.000294	0.000869	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—CCR5—atopic dermatitis	0.000288	0.000853	CbGpPWpGaD
Levorphanol—OPRM1—GPCR ligand binding—CXCL8—atopic dermatitis	0.000287	0.000849	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—TAC1—atopic dermatitis	0.000277	0.00082	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—NPS—atopic dermatitis	0.000277	0.00082	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CXCR3—atopic dermatitis	0.000272	0.000804	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—CCL5—atopic dermatitis	0.00027	0.0008	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—CCR5—atopic dermatitis	0.000268	0.000794	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CCR3—atopic dermatitis	0.000263	0.000777	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—IL5—atopic dermatitis	0.000258	0.000762	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CXCL10—atopic dermatitis	0.00025	0.000741	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—CCR5—atopic dermatitis	0.000244	0.000721	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—TAC1—atopic dermatitis	0.000234	0.000693	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—NPS—atopic dermatitis	0.000234	0.000693	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CXCR3—atopic dermatitis	0.00023	0.000679	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CXCL10—atopic dermatitis	0.00022	0.00065	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000219	0.000648	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IL5—atopic dermatitis	0.000218	0.000644	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CCL5—atopic dermatitis	0.000216	0.000638	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—IL2—atopic dermatitis	0.000209	0.000619	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—NGF—atopic dermatitis	0.0002	0.000591	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—CXCL8—atopic dermatitis	0.000199	0.000588	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CCR5—atopic dermatitis	0.000194	0.000575	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000192	0.000568	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—IL2—atopic dermatitis	0.00019	0.000562	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CCL5—atopic dermatitis	0.000189	0.000559	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CXCL10—atopic dermatitis	0.000186	0.000549	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—IL2—atopic dermatitis	0.000183	0.000543	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—NGF—atopic dermatitis	0.000175	0.000518	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—CXCL8—atopic dermatitis	0.000174	0.000516	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CCR5—atopic dermatitis	0.00017	0.000504	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—IL2—atopic dermatitis	0.000167	0.000493	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—NFKBIA—atopic dermatitis	0.000165	0.000487	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000162	0.00048	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CCL5—atopic dermatitis	0.00016	0.000473	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—IL2—atopic dermatitis	0.000155	0.000459	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—NGF—atopic dermatitis	0.000148	0.000438	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—CXCL8—atopic dermatitis	0.000147	0.000436	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—NFKBIA—atopic dermatitis	0.000144	0.000427	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CCR5—atopic dermatitis	0.000144	0.000426	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—IL2—atopic dermatitis	0.000141	0.000417	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—NFKBIA—atopic dermatitis	0.000122	0.000361	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CXCL8—atopic dermatitis	0.000117	0.000347	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—IL2—atopic dermatitis	0.000112	0.000332	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—IL6—atopic dermatitis	0.000112	0.00033	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MAPK8—atopic dermatitis	0.000103	0.000306	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CXCL8—atopic dermatitis	0.000103	0.000305	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—IL2—atopic dermatitis	9.84e-05	0.000291	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—IL6—atopic dermatitis	9.79e-05	0.00029	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MAPK8—atopic dermatitis	9.06e-05	0.000268	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CXCL8—atopic dermatitis	8.7e-05	0.000257	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IL2—atopic dermatitis	8.32e-05	0.000246	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—IL6—atopic dermatitis	8.27e-05	0.000245	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MAPK8—atopic dermatitis	7.65e-05	0.000227	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—IL6—atopic dermatitis	6.6e-05	0.000195	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—IL6—atopic dermatitis	5.78e-05	0.000171	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IL6—atopic dermatitis	4.89e-05	0.000145	CbGpPWpGaD
